Tecentriq OverviewAtezolizumab (trade name Tecentriq) is a fully humanized, engineered monoclonal antibody of IgG1 isotype against the protein programmed cell death-ligand 1 (PD-L1). In 2015, it was in clinical trials as an immunotherapy for several types of solid tumors. It was under investigation by Genentech/Roche. In April 2016, Roche announced that atezolizumab had been granted fast track status for lung cancer by the FDA. In Ma...
Read more Tecentriq Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Atezolizumab
Recent Tecentriq Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 1200mg/20ml
NDC Database Records for Tecentriq: (1 result)Sorted by National Drug Code
- 50242-917 Tecentriq 1200 mg/20ml Intravenous Injection, Solution by Genentech, Inc.